Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Third People's Hospital of Hangzhou

NCT06002750 is registered in ClinicalTrials.gov with The Third People's Hospital of Hangzhou as lead sponsor.

NCT NCT06002750
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06002750 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Third People's Hospital of Hangzhou
Lead sponsor
The Third People's Hospital of Hangzhou
Phase
Observational
Overall status
Completed
Start date
November 24, 2021
Completion date
November 24, 2022
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dermatomyositis, inflammation, myocardial repolarization